600196.SH
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 22.79
−3.27%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenCNY 21.85
From 52W high−29.11%
Volume14.39M
Market capCNY 60.86B
P/E (TTM)18.1x
P/S (TTM)1.4x
Div yield1.77%
Key dataSep 18, 2026
Open
CNY 21.85
From 52W high
−29.11%
Volume
14.39M
Market cap
CNY 60.86B
ValuationView details →
P/E (Fwd)
22.0x
EV/EBITDA
10.4x
P/E (TTM)
18.1x
RSI (14)
42.8
MomentumView details →
1D Return
−3.27%
YTD Return
−16.84%
Similar companies
Latest newsMore news →
Shanghai Fosun Pharmaceutical (Group) repurchased 1.3 million of its own shares on September 18 at HK$17.35–17.58 per share for about HK$22.77 million, bringing cumulative buybacks to 9.759 million shares, or 1.8% of issued shares.2d agoShanghai Fuzhenkang Biotechnology Co., Ltd. was established, jointly held by Fosun Pharma's wholly owned subsidiary Fosun Diagnostics Technology (Shanghai) Co., Ltd. and other shareholders.4d agoFosun Pharma repurchased 1.3 million of its own shares on the Hong Kong Stock Exchange on September 16, 2026 at HK$16.91–17.26 per share for a total of HK$22.2439 million, to be held as treasury shares.4d ago